Memory in Aging, Mild Cognitive impairment and AD
衰老、轻度认知障碍和 AD 中的记忆
基本信息
- 批准号:6796586
- 负责人:
- 金额:$ 26.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs diseaseagingbehavioral /social science research tagbioimaging /biomedical imagingbrain imaging /visualization /scanningclinical researchcognition disordersevoked potentialsfunctional magnetic resonance imaginghuman old age (65+)human subjectlongitudinal human studymemorymemory disordersneural information processingneuropsychological testssemanticstime perceptiontime resolved data
项目摘要
The proposed studies, by a newly independent investigator, aim to further our understanding of the physiological bases of the memory impairments found with aging and in patients with memory disorders. We will use Event-Related Potentials (ERPs) and Functional-Magnetic Resonance Imaging (FMRI) to investigate verbal memory processes in aging, Mild Cognitive Impairment (MCI), and Alzheimer's disease (AD). The specific brain potentials of interest are the N400, a negativity which peaks near 400 msec post-stimulus, and the late positive component (LPC) which follows. The N400 amplitude is sensitive to the ease/difficulty with which the eliciting word is integrated with its semantic context. The LPC has been closely linked to memory processes. We have adapted our ERP word repetition paradigm, which utilizes repeating auditory context/visual target word pairs during a semantic categorization task, for use with FMRI. This paradigm provides electrophysiological measures of both implicit and explicit verbal memory processes, and may shed light on the neuroanatomical substrates of these processes. We have shown that amnesic patients have an abnormal reduced ERP repetition effect to "congruous" category-exemplar words (the "LPC repetition effect"). The degree of this reduction correlates well with severity of declarative memory impairment. We have recently found that patients with MCI also have a reduced LPC word repetition effect. Further, a severely reduced LPC repetition effect amplitude appears to increase the likelihood of subsequent conversion to AD. Our main specific aims are: 1) To quantify the decline in the ERP word repetition effects that occurs in normal aging. A reduced ERP word repetition effect may be a sensitive sign of memory impairment and pathological brain aging. 2) To test the sensitivity of our ERP and FMRI paradigms to mild AD and to "pre-clinical" AD. 3) To improve our understanding of which neural substrates generate the N400 and LPC in normal elderly and in patients with very early AD. Research design: Case-control and longitudinal studies and ERPs in conjunction with FMRI studies and selected behavioral measures. Methods: ERP and FMRI data will be obtained from normal, MCI, and AD subjects during semantic categorization. Repetition and congruity (degree of fit with a category) will be varied systematically to modulate the N400 and LPC. Comparisons of N400 and LPC characteristics will be made (between-and within- group) and related to memory and other cognitive abilities. Event-related FMRI BOLD response patterns will be used to constrain source dipole models for the neural generations of the N400 and LPC.
由一位新近独立的研究者提出的这项研究,旨在进一步加深我们对衰老和记忆障碍患者记忆障碍的生理基础的理解。我们将使用事件相关电位(ERPs)和功能磁共振成像(FMRI)来研究衰老、轻度认知障碍(MCI)和阿尔茨海默病(AD)的言语记忆过程。特定的脑电位是N400,在刺激后400毫秒左右达到峰值的负性成分,以及随后的晚期正性成分(LPC)。N400振幅对引出词与其语义语境整合的难易程度敏感。LPC与记忆过程密切相关。我们已经调整了我们的ERP单词重复范式,该范式在语义分类任务中利用重复的听觉上下文/视觉目标单词对,用于FMRI。这种模式提供了内隐和外显言语记忆过程的电生理测量,并可能阐明这些过程的神经解剖学基础。我们发现,失忆症患者对“一致”类别-范例词的ERP重复效应异常降低(即“LPC重复效应”)。这种减少的程度与陈述性记忆障碍的严重程度密切相关。我们最近发现轻度认知障碍患者的LPC单词重复效应也有所降低。此外,严重降低的LPC重复效应幅度似乎增加了随后转化为AD的可能性。我们的主要具体目标是:1)量化在正常衰老中发生的ERP单词重复效应的下降。ERP单词重复效应的降低可能是记忆障碍和病理性脑老化的敏感信号。2)测试ERP和FMRI模式对轻度AD和“临床前”AD的敏感性。3)提高我们对正常老年人和极早期AD患者中N400和LPC产生的神经底物的认识。研究设计:病例对照和纵向研究,erp结合FMRI研究和选择的行为测量。方法:在语义分类过程中获取正常、轻度认知障碍和AD被试的ERP和FMRI数据。重复和一致性(与类别的拟合程度)将系统地变化以调节N400和LPC。将比较N400和LPC的特征(组间和组内),并与记忆和其他认知能力有关。事件相关的FMRI BOLD响应模式将用于约束N400和LPC神经代的源偶极子模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John M Olichney其他文献
John M Olichney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John M Olichney', 18)}}的其他基金
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
大剂量维生素 D 补充剂治疗无痴呆症老年人的 II 期随机对照试验
- 批准号:
9904383 - 财政年份:2017
- 资助金额:
$ 26.88万 - 项目类别:
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
无痴呆老年人大剂量维生素 D 补充剂的 II 期随机对照试验
- 批准号:
10720845 - 财政年份:2017
- 资助金额:
$ 26.88万 - 项目类别:
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
大剂量维生素 D 补充剂治疗无痴呆症老年人的 II 期随机对照试验
- 批准号:
9751690 - 财政年份:2017
- 资助金额:
$ 26.88万 - 项目类别:
Memory in Aging, Mild Cognitive impairment and AD
衰老、轻度认知障碍和 AD 中的记忆
- 批准号:
6533886 - 财政年份:2001
- 资助金额:
$ 26.88万 - 项目类别:
Memory in Aging, Mild Cognitive impairment and AD
衰老、轻度认知障碍和 AD 中的记忆
- 批准号:
6647091 - 财政年份:2001
- 资助金额:
$ 26.88万 - 项目类别:
Memory in Aging, Mild Cognitive impairment and AD
衰老、轻度认知障碍和 AD 中的记忆
- 批准号:
6943484 - 财政年份:2001
- 资助金额:
$ 26.88万 - 项目类别:
Memory in Aging, Mild Cognitive impairment and AD
衰老、轻度认知障碍和 AD 中的记忆
- 批准号:
6371148 - 财政年份:2001
- 资助金额:
$ 26.88万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 26.88万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 26.88万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 26.88万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 26.88万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 26.88万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10390278 - 财政年份:2021
- 资助金额:
$ 26.88万 - 项目类别:
Evaluating the role of the caregiver in the quality of life of people with Parkinson?s disease: opportunities for intervention
评估护理人员在帕金森病患者生活质量中的作用:干预机会
- 批准号:
10088327 - 财政年份:2020
- 资助金额:
$ 26.88万 - 项目类别:
Evaluating the role of the caregiver in the quality of life of people with Parkinson?s disease: opportunities for intervention
评估护理人员在帕金森病患者生活质量中的作用:干预机会
- 批准号:
9907351 - 财政年份:2020
- 资助金额:
$ 26.88万 - 项目类别:
Dementia and hearing loss: Using preclinical models to uncover the mechanisms that accelerate cognitive decline in Alzheimer?s disease
痴呆和听力损失:利用临床前模型揭示加速阿尔茨海默病认知能力下降的机制
- 批准号:
429089 - 财政年份:2019
- 资助金额:
$ 26.88万 - 项目类别:
Studentship Programs
Thalamic Contributions to Functional Network Abnormalities in Alzheimer''s Disease
丘脑对阿尔茨海默病功能网络异常的贡献
- 批准号:
10415553 - 财政年份:2019
- 资助金额:
$ 26.88万 - 项目类别:














{{item.name}}会员




